Normal view MARC view ISBD view

Transparency in neonatal intensive care. [electronic resource]

By:

King, N M

Producer: 19920724Description: 18-25 p. digitalISSN:

0093-0334

Subject(s):

In: The Hastings Center report vol. 22

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

1 Role of thymus-eicosanoids in the immune response.
by Juzan, M
2 Pancytopenia induced by low-dose methotrexate in a haemodialysis patient treated for bullous pemphigoid.
by Seneschal, J
3 Allelic imbalance study of 16q in human primary breast carcinomas using microsatellite markers.
by Dorion-Bonnet, F
4 Inhibition of signal transduction by the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin results in cytostasis and apoptosis.
by Hostein, I
5 5-Lipoxygenase gene expression in the thymus.
by Hostein, I
6 Polymerase chain reaction diagnosis of t(14;18) from paraffin-embedded tissues fixed with Holland Bouin fluid.
by Hostein, I
7 High-depth sequencing of paired primary and metastatic tumours: Implications for personalised medicine.
by Grellety, T
8 Evaluation of MDM2 and CDK4 amplification by real-time PCR on paraffin wax-embedded material: a potential tool for the diagnosis of atypical lipomatous tumours/well-differentiated liposarcomas.
by Hostein, I
9 A 1-kb Bcl-2-PCR fragment detection in a patient with follicular lymphoma and development of a new diagnostic PCR method.
by Hostein, I
10 Evolution of BCL-2/IgH hybrid gene RNA expression during treatment of T(14;18)-bearing follicular lymphomas.
by Soubeyran, P
11 Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperone.
by Clarke, P A
12 Treatment with the mTOR inhibitor temsirolimus in patients with malignant PEComa.
by Italiano, A
13 Competitive polymerase chain reaction to quantify tumor cells in peripheral blood of patients with T(14;18)-bearing follicular non-Hodgkin's lymphoma: an exploratory study in 8 patients.
by Debled, M
14 Prognosis and predictive value of KIT exon 11 deletion in GISTs.
by Bachet, J-B
15 Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs.
by Emile, J F